Status:
RECRUITING
Life-2023-02 Esophagogastric Variceal Bleeding
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Acute Esophageal Variceal Hemorrhage
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
Detailed Description
Participants with acute esophagogastric variceal bleeding in 5 days and under stable status will be included in this study. All the patients will take CTP test to confirm the blood flow status of the ...
Eligibility Criteria
Inclusion
- acute esophagogastric bleeding with hepatic cirhosis;
- stable status (no active bleeding)
Exclusion
- endoscopic test limitation;
- previous acute esophagogastric bleeding treatment history;
- ICU;
- pregnant;
- Immunity disabled;
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 10 2026
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06011980
Start Date
August 1 2023
End Date
August 10 2026
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hanzhou, Zhejiang, China, 310000